KSR1
Basic information
Region (hg38): 17:27456448-27626438
Previous symbols: [ "KSR" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KSR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 38 | 39 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 38 | 1 | 0 |
Variants in KSR1
This is a list of pathogenic ClinVar variants found in the KSR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-27577565-G-A | not specified | Uncertain significance (May 30, 2024) | ||
17-27577567-T-C | not specified | Uncertain significance (Dec 13, 2021) | ||
17-27577568-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
17-27577591-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
17-27582675-A-C | not specified | Uncertain significance (Jun 10, 2022) | ||
17-27582688-C-T | not specified | Uncertain significance (Aug 28, 2023) | ||
17-27582759-A-C | not specified | Uncertain significance (Aug 17, 2021) | ||
17-27582801-C-A | not specified | Uncertain significance (Jun 22, 2023) | ||
17-27582921-C-T | not specified | Uncertain significance (Jun 02, 2023) | ||
17-27582958-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
17-27582961-G-A | not specified | Uncertain significance (Oct 29, 2021) | ||
17-27582985-G-A | not specified | Uncertain significance (Jun 09, 2022) | ||
17-27582997-C-A | not specified | Uncertain significance (Nov 10, 2022) | ||
17-27582997-C-T | not specified | Uncertain significance (Jul 19, 2023) | ||
17-27583006-G-A | not specified | Uncertain significance (Jul 12, 2023) | ||
17-27583048-G-A | not specified | Uncertain significance (May 12, 2024) | ||
17-27583083-A-C | not specified | Uncertain significance (Apr 19, 2023) | ||
17-27588516-G-A | not specified | Uncertain significance (Jan 31, 2023) | ||
17-27592585-G-A | not specified | Uncertain significance (Oct 03, 2022) | ||
17-27597293-T-C | not specified | Uncertain significance (Nov 09, 2021) | ||
17-27597347-C-T | not specified | Uncertain significance (Aug 02, 2022) | ||
17-27603861-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
17-27603863-C-G | not specified | Uncertain significance (Aug 08, 2023) | ||
17-27603866-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
17-27604684-G-A | not specified | Uncertain significance (Sep 16, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KSR1 | protein_coding | protein_coding | ENST00000398988 | 19 | 169792 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0698 | 0.930 | 124647 | 0 | 14 | 124661 | 0.0000562 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.00 | 360 | 484 | 0.744 | 0.0000319 | 4911 |
Missense in Polyphen | 123 | 183.59 | 0.66999 | 1826 | ||
Synonymous | -0.543 | 213 | 203 | 1.05 | 0.0000140 | 1519 |
Loss of Function | 4.28 | 10 | 38.7 | 0.258 | 0.00000191 | 445 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000116 | 0.000116 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000556 | 0.0000556 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000667 | 0.0000619 |
Middle Eastern | 0.0000556 | 0.0000556 |
South Asian | 0.0000670 | 0.0000654 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Scaffolding protein that is part of a multiprotein signaling complex. Promotes phosphorylation of Raf family members and activation of downstream MAP kinases. Promotes activation of MAPK1 and/or MAPK3, both in response to EGF and to cAMP. Does not have kinase activity by itself. {ECO:0000250|UniProtKB:Q61097}.;
- Pathway
- C-type lectin receptor signaling pathway - Homo sapiens (human);Tuberculosis - Homo sapiens (human);Ras signaling pathway - Homo sapiens (human);EGF-Ncore;TNF alpha Signaling Pathway;Brain-Derived Neurotrophic Factor (BDNF) signaling pathway;Pathways in clear cell renal cell carcinoma;Ras Signaling;MAP2K and MAPK activation;RAF activation;Disease;Signal Transduction;ceramide signaling pathway;ErbB1 downstream signaling;Negative regulation of MAPK pathway;RAF/MAP kinase cascade;MAPK1/MAPK3 signaling;MAPK family signaling cascades;Signaling by RAS mutants;Signaling by high-kinase activity BRAF mutants;Signaling by moderate kinase activity BRAF mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Diseases of signal transduction;PDGFR-beta signaling pathway;Ceramide signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.151
Haploinsufficiency Scores
- pHI
- 0.308
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.495
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.967
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ksr1
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); skeleton phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); neoplasm; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- MAPK cascade;Ras protein signal transduction;cAMP-mediated signaling;regulation of cell population proliferation;regulation of MAP kinase activity;positive regulation of MAPK cascade
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;cytosol;membrane;ruffle membrane;protein-containing complex
- Molecular function
- protein kinase activity;MAP-kinase scaffold activity;protein binding;ATP binding;protein C-terminus binding;mitogen-activated protein kinase kinase binding;metal ion binding;chaperone binding;Hsp90 protein binding;14-3-3 protein binding